But just a few weeks later, Blue Cross Blue Shield of Massachusetts announced that effective January 2026, they would cease covering GLP-1s entirely for weight loss for their fully insured population
Balette says "weight-loss medications," he does not mean only GLP-1s
Ozempic (Semaglutide): Originally developed for type 2 diabetes, Ozempic has proven to be highly effective for appetite reduction and weight control
Foundayo is a different weight loss pill, but it is not yet available in the UK
Importantly, Sermorelin does not replace growth hormone
At the meeting of the Pharmacy Compounding Advisory Committeewhich last month added eight new members, many with ties to telehealth companies and wellness clinicsFDA researchers argued that the scientific evidence supporting BPC-157 was weak